Document:

<pre> Exhibit 10.2

EMPLOYMENT AGREEMENT OF CHARLES FOERG

THIS AGREEMENT is made and entered into effective the 1st of September,
2002 by and between RPM Technologies, Inc. ("RPM"), ("Employer"), and
Charles Foerg ("Employee").

WITNESSETH:

WHEREAS, Employer is a corporation, duly organized under the laws of the
state of Delaware; and

WHEREAS, Employee has expertise in Employer's business which is engaged in
the business of  light manufacture ring;

WHEREAS, Employer desires to employ Employee, and Employee desires to
accept employment with Employer upon the terms and conditions herein set
forth; and

NOW, THEREFORE, in consideration of the mutual promises, covenants and
agreements herein, and intending to be legally bound hereby, the parties
mutually agree as follows:

2.      Employment and Term

Employer hereby employs Employee and Employee hereby accepts employment
from Employer to perform the duties set forth below, for an initial term of
three (3) years, subject to the farther provisions of this Agreement, and
thereafter shall be automatically extended for subsequent five (5) year
terms unless terminated as provided herein.  Employee's employment
hereunder shall be continued thereafter from term to term until either
party shall give one hundred eighty (180) days prior written notice of
termination. Notwithstanding the foregoing, this Agreement may be sooner
terminated as provided in Paragraph 8 hereof.

2.    Duties.

Employee shall devote his full time and efforts to the business of
Employer, and shall be a an officer of RPM, holding the title of President
performing the duties of such office for Employer.

3.   Compensation.

During the initial term of this Agreement, Employee shall receive as
compensation for his services, an annual base salary of  Eighty-five
Dollars ($85,000). Employee shall receive a signing bonus of 300,000 shares
of restricted common stock upon execution of this Agreement. During the
subsequent terms of employment under this agreement, Employer shall
negotiate Employee's annual base salary in good faith; provided, however,
that Employer shall pay Employee an annual base salary in such subsequent
terms of employment in an amount no less than the annual base salary paid
Employee during the initial term hereunder.  Employee shall have an option
to purchase up to 1,000,000 shares of RPM restricted stock under rule 144
at a cost of  $0.50; this option shall remain open for three (3) years with
an option to renew said option for an additional three (3) years.

4.  Fringe Benefits.

Employer shall provide Employee with health care and medical insurance
coverage by RPM and shall be entitled to participate in all qualified or
unqualified employee benefit plans subject only to those prerequisites
required of other officers and employees.  Employee shall receive such
other fringe benefits as Employer may determine from time to time in its
sole discretion. Employee shall be entitled to six (6) weeks paid vacation
each year. If Employee is unable to perform Employee's duties by reason of
illness or incapacity for a consecutive period of more than two weeks, the
compensation payable after the aforesaid period shall be Five Thousand
Dollars ($5,000) per month. Upon return to full employment, full
compensation shall be reinstated. If Employee is unable to perform or is
absent from employment for a period of more than eighteen (18), months,
Employer may terminate this Employment Agreement, without further cause.

5.   Reimbursement for expenses.

Employer shall reimburse Employee for all ordinary and reasonable expenses
incurred by Employee in connection with the business of Employer,
Reimbursement shall be made to Employee by Employer no later than within
thirty (30) business days following Employee's submittal to Employer of a
reasonable itemization and documentation of such expenses incurred by
Employee within the prior approval procedures established by the employer
through RPM.

6.    Employer's Documents.

Employee shall upon termination of employment with Employer, for any reason
whatsoever, deliver to Employer any and all records, forms, manuals,
notebooks, instructional materials, contracts, lists of names or other
customer data and any other documents, computer software or the like which
have come into Employee's possession by reason of employment with Employer
or which Employee holds for Employer, irrespective of whether or not any of
said items were prepared by Employee, and Employee shall not retain
memoranda or copies of any said items; nor shall Employee disclose such
records forms, contracts lists or names or other customer data or trade
secrets to any other person, firm or entity, either before or after
termination of employment with Employer.

7.      Disclosure of Information.

Employee recognizes and acknowledges that Employer's documents, techniques,
procedures and processes as they exist from time to time, are valuable,
special and unique assets of Employers business. Employee ,will not, during
the term of employment or after the termination thereof, carry away,
utilize or disclose any of the technique, procedures, processes or any of
the information contained in said Employees documents or computer data or
any part thereof to any person, firm, corporation, association or other
entity for any reason for purpose whatsoever.  In the event of a breach or
threatened breach by Employee of the provisions of this paragraph, Employer
shall be entitled to injunction restraining Employee from disclosing or
utilizing, in whole or in part, any of the above information.  Nothing
herein shall be construed as prohibiting Employer from pursuing any other
remedies available for such breach or threatened breach, including the
recovery of damages.

8.  Termination of Employment.

Employer may not terminate Employee's employment hereunder during the
initial period, except for cause, as defined herein. Thereafter, either
party hereto may terminate this Agreement without cause upon one hundred
eighty (180) days written notice to the other party.

a.     Termination for Cause - By Employer.  Employer may terminate this
Agreement for cause, which shall be defined as:

i.     In the event that Employee refuses to carry out the reasonable and
lawful directions of Employer or Employee shall defraud Employer, embezzle
funds of Employer, engage in willful misconduct, proven fraud or dishonesty
in the performance of Employee's duties hereunder;

ii.     In the event that Employee breaches any of the covenants contained
in this Agreement and such breach has not been cured to the reasonable
satisfaction of Employer; or

iii.   In the event that Employee is materially incapacitated from
performing Employee's duties hereunder by reason of illness or other
disability, but only in the event that such incapacity or disability
continues for a continuous period of at least Eighteen (18) months.

iv.   Employee's failure to follow  Employer's the rules and regulations
regarding non-disclosure and disclosure of  Employer's trade secrets.

b.    Termination for cause-By Employee . Employee may terminate this
Agreement for cause, which shall be defined as being in the event that
Employer breaches any of the covenants contained in this Agreement and such
breach has not been cured to the reasonable satisfaction of Employee.

c.    Termination on Death of Employee.  This Agreement shall terminate
upon the death of Employee.

d.    Severance Pay.  In the event of the termination for cause of Employee
as provided in this Agreement, Employee shall not receive any severance or
termination pay, except for salary, bonuses and benefits accrued or earned,
but unpaid as of the date of Employee's termination. In the event of
termination by employer for any other reason as provided herein, Employee
shall receive, at the time of termination, a lump sum severance payment, in
addition to salary, bonuses and benefits accrued or earned, but unpaid as
of the date of Employee's termination, in an amount equal to Employee's
salary and benefits payable under the terms hereof for a period of one
hundred eighty  (180) days. All stock options are vested and are
irrevocable at the start of this agreement. In the event that termination
for cause pursuant to Section  8(a)(i) occurs then all stock options are
automatically revoked upon discovery.

9.    Notice.

All demands, notices and other communications to be given hereunder shall
be in writing and shall be deemed received when personally delivered or
sent by registered or certified United States mail, return receipt
requested, postage prepaid, and addressed as follows:

Employee: Charles Foerg C/o RPM. 21061 West Braxton Plainfield, IL 60544

Employer: RPM. 21061 West Braxton Plainfield, IL 60544

or at such other address the parties may from time to time designate by
written notice hereunder.

10.    Waiver.

Waiver by Employer of a breach of any provision of this Agreement by
Employee shall not be construed as a waiver of any subsequent breach by
Employee.

11.  Assignment.

All rights and obligations under this Agreement shall be personal to
Employee and shall not be assignable by Employee.  The rights and
obligations of Employer under this Agreement shall inure to the benefit of
and shall be binding upon Employer, its successors and assigns.

12.   Confidentiality of this Agreement.

Employer and employee agree to keep and maintain the terms and provisions
of this agreement absolutely confidential and shall not disclose its terms
to any person or entity.

13.   Governing Law.

This Agreement shall be construed in accordance with and governed by the
laws of the state of Illinois.  Venue for any legal action arising from
this Agreement  shall lie only in Cook County, Illinois.

14.   Heading's.

Any headings preceding the text of the paragraphs hereof are inserted
solely for convenience of reference and shall not constitute a part of this
Agreement nor shall they affect its meaning, construction or effect.

15.  Saving Clause.

If any provision or clause of his Agreement, or application thereof to any
person or circumstances is held invalid or unlawful, such invalidity or
unlawfulness shall not effect any other provision or cause of this
Agreement or application thereof which can be given effect without the
invalid or unlawful provision, clause or application.

16.  Entire Agreement.

This Agreement contains the entire understanding between the parties
hereto.  There have been no oral or other agreements of any kind whatsoever
as a condition precedent or inducement to the signing of this Agreement or
otherwise concerning this Agreement or the subject matter hereof  No
changes, modifications or alterations of any of the terms and provisions,
contained in this Agreement, shall be effective unless changed, modified,
or altered in writing and signed by both parties hereto.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed as of the day and year first above written.

Employee:/S/ CHARLES FOERG
CHARLES FOERG

Employer:/S/ RANDY ZYCH
RANDY ZYCH CEOExhibit 10.9

                    CONSULTING AGREEMENT

     The  undersigned   parties   hereby   agree   that    IGENE
Biotechnology,  Inc.  ("IGENE")  shall  employ Martin L.  Gerson
("Consultant") upon the terms and conditions hereinafter  stated
to provide consulting services and assistances in the  following
areas:

1).  To   secure   for   Igene  a  manufacturing partner for the
     production of AstaXin(R).
2).  To  coordinate  and monitor  the startup  of  the  business
     relationship with said manufacturing partner for  at  least
     two years.
3).  To  provide  other  advisory  services  to  the  Board   of
     Directors of Igene from time to time, as  the  Board  might
     designate  and  as  might  be  considered,  by both parties
     hereto,  as appropriate within the scope of this consulting
     relationship.

     The  work  to  be performed by Consultant shall  consist of
such  tasks  as may be mutually agreed.  Services to be provided
shall  in  all  cases  by provided in accordance with guidelines
established by IGENE.  The Consultant shall have no authority to
commit Igene  to any specific project, operation, or obligation.

     The term of this Agreement shall commence on April 15, 2002
and  shall  terminate  on  April  15,  2004.   Pursuant  to this
Agreement the Consultant shall receive compensation for services
rendered in the form of 12,000,000 unregistered shares  of Igene
Common  Stock.    Consultant   shall   be   also   entitled   to
reimbursement  for  reasonable  traveling  expenses  incurred in
performing  services for IGENE if such travel expenses have been
approved  in  advance  as  appropriate  for  reimbursement by an
officer of IGENE.  Reimbursement shall normally  be  made within
(15) days after presentation of an itemized   invoice  for  such
expenses with appropriate receipts or  other evidence of payment
of  such   expenses  attached  thereto.    Consultant  shall  be
responsible  for  all  other  expenses incurred by Consultant in
performing services, except for  telephone   calls  made  in the
course of work done for IGENE.

     During  the  term  of  this  Agreement, Consultant shall be
deemed to  be  an  independent  contractor and shall not for any
purposes be  deemed  to be an employee of IGENE.   In performing
services hereunder,  Consultant  shall  also  not enter into any
contract on behalf of IGENE or otherwise attempt to commit IGENE
to any contractual  agreement  without  IGENE's  express written
approval.

     During  the term of this Agreement, Consultant acknowledges
that he may  obtain  access  to  information  of  IGENE which is
confidential and proprietary to IGENE, including but not limited
to information concerning new products and processes,  processes
and products under development, other technological innovations,
manufacturing and marketing.  Such written information  shall be
clearly  marked  as   confidential.    Oral  disclosures  of   a
proprietary nature will  be  summarized  in  writing  and marked
confidential.  Consultant may also develop information for IGENE
which has value because  of  its  confidentiality.    Consultant
agrees that all of such  information  which Consultant learns of,
conceives or reduces to practice in  connection  with  or  as  a
result  of  his  employment  hereunder  is  and shall remain the
property solely of IGENE and Consultant will not  disclose  such
information to any  third  parties or use or assist or allow any
third parties to use such  information  for  the  benefit of any
party other than IGENE with out IGENE's prior  written  consent,
both during the term of this Agreement and after  termination or
expiration of the Agreement, so long as any of such  information
remains  confidential.   Consultant  further  agrees  that  upon
termination  or  expiration  of  this Agreement, Consultant will
provide a list of all contacts made by Consultant on  Behalf  of
IGENE  and  will  return  to  IGENE  all  documents,   writings,
illustrations, and other  such  materials  produced  by  him  or
coming into  his  possession  by  or through his employment with
IGENE  and  agrees  that  all  such  materials  are at all times
IGENE's property.   Consultant  further  agrees  to refrain from
consulting with any other company besides  IGENE  concerning the
production of astaxanthin during and  for  a  period of five (5)
years following termination or expiration of this Agreement.

     This  Agreement contains the entire   understanding between
the  parties  hereto  and   supersedes   all   other   oral  and
written   agreements   or   understandings   between  them.   No
modification or  addition  hereto  or  waiver  or   cancellation

<PAGE>

of any terms hereof  shall be valid   unless   made  in  writing
signed  by the party against whom such modification is sought to
be enforced.

     This  Agreement   shall   be   deemed   to  be  made in and
enforceable in accordance with the laws of the State of Maryland.

     IN WITNESS WHEREOF,   the undersigned parties have executed
this Agreement as of the 21st day of August, 2002.

CONSULTANT                   IGENE BIOTECHNOLOGY, INC.

/s/ Martin L. Gerson         /s/ Michael G. Kimelman
____________________         _________________________
    Martin L. Gerson             Michael G. Kimelman
                                 Chairman of the Board
                                 of Directors

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]